Polycystic Ovarian Syndrome Ups Risk of Type 2 Diabetes

This article originally appeared here.
Share this content:
Polycystic Ovarian Syndrome Ups Risk of Type 2 Diabetes
Polycystic Ovarian Syndrome Ups Risk of Type 2 Diabetes

(HealthDay News) – Middle-aged women with polycystic ovary syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a prospective long-term study published online June 14 in Diabetes.

Alessandra Gambineri, MD, from the University of Bologna in Italy, and colleagues conducted a long-term prospective study of a cohort of 255 women with PCOS, followed from youth to middle age, with a mean follow-up of 16.9 years.

The researchers found that six women had diabetes at baseline, and another 42 women developed diabetes over the study follow-up, yielding an incidence rate for type 2 diabetes of 1.05 per 100 person-years. At the end of follow-up, the age-standardized prevalence of diabetes was 39.3%, which was significantly higher than that of the general Italian female population of a similar age (5.8%). As body mass index (BMI), fasting glucose, and glucose area under the curve at baseline increased, the risk of developing type 2 diabetes significantly increased. The likelihood of developing diabetes decreased significantly as sex hormone-binding globulin (SHBG) levels increased.

"This study demonstrates that the risk of type 2 diabetes is markedly elevated in middle-aged women with PCOS and suggests including BMI, glucose, and SHBG-circulating levels in the risk stratification," the authors write.

Abstract
Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs